Epicutaneous immunotherapy for treating peanut allergy in children [ID1255]
Discontinued
Reference number: GID-TA10763
As you will be aware The Department for Health and Social Care has asked NICE to conduct an appraisal of Epicutaneous immunotherapy for treating peanut allergy in children.
Please note that following on from a request received from the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin during mid-March 2022 when we will write to consultees and commentators about how they can get involved.